Alzheimer gene APOE4 damages brain blood vessels

APOE4 has long been known as a risk marker for Alzheimer’s disease. But the precise mechanisms of its damage remained unclear. Researchers now show that APOE4 actively damages blood vessels in the brain and simultaneously disrupts the systems responsible for clearing harmful proteins. In experiments, they were able to reverse some of these effects, revealing promising new targets for Alzheimer’s, Parkinson’s, and other neurodegenerative diseases.

APOE4 encodes a variant of the protein apolipoprotein E, which normally helps transport fats in the brain. The APOE4 variant does this less efficiently. But the new findings go further: APOE4 also weakens the blood-brain barrier (the protective layer separating blood vessels from brain tissue). This allows harmful substances to reach the brain more easily. At the same time, the system responsible for clearing amyloid-beta and tau proteins becomes impaired.

Damage that can be reversed

What is particularly notable is that some of the damage observed in experiments appeared reversible. That is scientifically encouraging: it suggests APOE4 does not determine an inevitable fate. The researchers identified specific molecular targets that could in principle be influenced pharmacologically, not just for Alzheimer’s, but also for Parkinson’s and other diseases involving protein aggregation (the buildup of misfolded proteins inside cells).

Cautious optimism

The results so far are primarily based on laboratory experiments. Whether the same effects occur in people carrying APOE4, and whether the therapeutic interventions identified will work clinically, requires further investigation. The researchers are cautious in their conclusions. Still, this represents a meaningful step: for the first time, a detailed picture has emerged of how APOE4 causes damage on multiple fronts simultaneously. That provides a stronger foundation for targeted treatments than earlier, more general insights.

Read the original article